Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma

References

• Azoulay E, Mokart D, Pene F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium – a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810–2818.
   PubMed Web of Science ®Google Scholar
• Lengline E, Chevret S, Moreau AS, et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50: 840–845.
   PubMed Web of Science ®Google Scholar
• Staudinger T, Stoiser B, Mullner M, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322–1328.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Lemiale V, Mokart D, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 2014; 40: 1106–1114.
   PubMed Web of Science ®Google Scholar
• Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481–487.
   PubMed Web of Science ®Google Scholar
• Legrand M, Max A, Peigne V, et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43–49.
   PubMed Web of Science ®Google Scholar
• Darmon M, Thiery G, Ciroldi M, et al. Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 2007; 33: 765–772.
   PubMed Web of Science ®Google Scholar
• Zuber B, Tran TC, Aegerter P, et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 2012; 40: 55–62.
   PubMed Web of Science ®Google Scholar
• Oeyen SG, Benoit DD, Annemans L, et al. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 2013; 39: 889–898.
   PubMed Web of Science ®Google Scholar
• Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011; 96: 231–237.
   PubMed Web of Science ®Google Scholar
• Wohlfarth P, Staudinger T, Sperr WR, et al. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 2014; 93: 1629–1636.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Soares M, Darmon M, et al. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1: 5.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Pene F, Darmon M, et al. Managing critically Ill hematology patients: time to think differently. Blood Rev 2015 . [Epub ahead of print]. doi: 10.1016/j.blre.2015.04.002.
   PubMed Web of Science ®Google Scholar
• Algrin C, Faguer S, Lemiale V, et al. Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma. Leukemia Lymphoma 2015; 56: 1240–1245.
   PubMed Web of Science ®Google Scholar
• Bird GT, Farquhar-Smith P, Wigmore T, et al. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 2012; 108: 452–459.
   PubMed Web of Science ®Google Scholar
• Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33: 2488–2493.
   PubMed Web of Science ®Google Scholar
• Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood 2015; 125: 22–32.
   PubMed Web of Science ®Google Scholar
• Project TIN-HsLPF. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994.
   PubMed Web of Science ®Google Scholar
• Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007; 109: 1857–1861.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Stein H, Vardiman JW. World health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
   Google Scholar
• Swerdlow SH CE, Harris NL, et al. World health irganization classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
   Google Scholar
• Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235–242.
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Pittaluga S, Shovlin M, et al. Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med 2013; 369: 1915–1925.
   PubMed Web of Science ®Google Scholar
• Fridrik MA, Thaler T, Hopfinger G, et al. Rituximab in combination with dose-dense therapy in duffuse large b-cell lymphoma (DLBCL). Austrian working party medical tumor therapy (AGMT) study NHL-8. Hematologica 2007; 92: 431. Abstract 1175.
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Walewski J, Dohner H, et al. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 2014; 124: 3870–3879.
   PubMed Web of Science ®Google Scholar
• Luminari S, Montanini A, Caballero D, et al. Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial. Ann Oncol 2010; 21: 1492–1499.
   PubMed Web of Science ®Google Scholar
• Lecuyer L, Chevret S, Thiery G, et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808–814.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
   PubMedGoogle Scholar
• Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin‘s disease staging classification. Cancer Res 1971; 31: 1860–1861.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–2963.
   PubMed Web of Science ®Google Scholar
• Schellongowski P, Benesch M, Lang T, et al. Comparison of three severity scores for critically ill cancer patients. Intensive Care Med 2004; 30: 430–436.
   PubMed Web of Science ®Google Scholar
• Roze des Ordons AL, Chan K, Mirza I, et al. Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer 2010; 10: 516.
   PubMed Web of Science ®Google Scholar
• Jackson K, Mollee P, Morris K, et al. Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. Leukemia Lymphoma 2014; 55: 97–104.
   PubMed Web of Science ®Google Scholar
• Schellongowski P, Wohlfarth P, Kundi M, et al. Incidence of intensive care unit admission, outcome, and post intensive care survival in patients with acute lymphocytic leukemia or burkitt lymphoma. Blood (Suppl) 2014; 124: 2633.
   Web of Science ®Google Scholar
• Rabbat A, Chaoui D, Montani D, et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol 2005; 129: 350–357.
   PubMed Web of Science ®Google Scholar
• Benoit DD, Depuydt PO, Vandewoude KH, et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006; 32: 93–99.
   PubMed Web of Science ®Google Scholar
• Song JU, Suh GY, Chung MP, et al. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 2011; 19: 491–495.
   PubMed Web of Science ®Google Scholar
• Wohlfarth P, Ullrich R, Staudinger T, et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Critical Care 2014; 18: R20.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Morrison VA, Dale DC, et al. Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy. Leukemia Lymphoma 2003; 44: 2069–2076.
   PubMed Web of Science ®Google Scholar
• Pettengell R, Johnsen HE, Lugtenburg PJ, et al. Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Support Care Cancer 2012; 20: 647–652.
   PubMed Web of Science ®Google Scholar
• Gisselbrecht C, Glass B, Mounier N, et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 2010; 28: 4184–4190.
   PubMed Web of Science ®Google Scholar
• Kewalramani T, Zelenetz AD, Hedrick EE, et al. High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood 2000; 96: 2399–2404.
   PubMed Web of Science ®Google Scholar
• Massion PB, Dive AM, Doyen C, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260–2270.
   PubMed Web of Science ®Google Scholar